Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$32.81 - $41.51 $95,247 - $120,503
2,903 Added 5.06%
60,299 $1.98 Million
Q2 2022

Aug 15, 2022

BUY
$35.59 - $48.1 $333,051 - $450,119
9,358 Added 19.48%
57,396 $2.21 Million
Q1 2022

May 13, 2022

BUY
$41.4 - $50.9 $108,426 - $133,307
2,619 Added 5.77%
48,038 $2.34 Million
Q4 2021

Feb 16, 2022

BUY
$37.73 - $46.74 $29,467 - $36,503
781 Added 1.75%
45,419 $2.05 Million
Q3 2021

Nov 10, 2021

BUY
$39.75 - $44.09 $167,784 - $186,103
4,221 Added 10.44%
44,638 $1.87 Million
Q2 2021

Jul 29, 2021

BUY
$40.83 - $45.48 $74,882 - $83,410
1,834 Added 4.75%
40,417 $1.75 Million
Q1 2021

Apr 29, 2021

BUY
$32.95 - $41.63 $1.27 Million - $1.61 Million
38,583 New
38,583 $1.57 Million

Others Institutions Holding NVST

About Envista Holdings Corp


  • Ticker NVST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 163,391,008
  • Market Cap $3.13B
  • Description
  • Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...
More about NVST
Track This Portfolio

Track Oliver Luxxe Assets LLC Portfolio

Follow Oliver Luxxe Assets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.